Forensic Analyst, Trudence Capital Advisors

Nitin Mangal

Nitin Mangal is a Research Analyst with more than 15 years of experience in Indian equities. He is Pioneer of Corporate Governance and Accounting Research in Indian Market and has successfully developed product for Institutional Investors named as "Analysis Beyond Consensus" during his association with Edelweiss Securities Ltd, Mumbai. Later during the career, he has worked with Veritas Investment Research Corporation, Canada as Asia Consultant covering Indian and US equities. He has been profiled by leading financial newspapers such as Wall Street Journal, Business Standard etc

Forensic Analyst

US Banks - USD13 Trillion in Loans, First Time Ever, as at Week 30 July

PG Electroplast: AC PLI & Product Launches to Drive Future Growth

2025 High Conviction Idea: PG Electroplast

The Beat Ideas: EFC(I) Limited - The Indian Wework!

The Beat Ideas: Prakash Industries Limited, A Mining Catalyst

Trudence Capital Advisors

Trudence Capital Advisors Private Limited is a SEBI-registered Research Analyst, holding SEBI registration number INH000015747. Our firm is dedicated to providing independent and unbiased research on Indian mid to large-cap companies. Trudence Capital is known for its counter-consensus views, with a focus on forensic research and on-ground primary investigations. Our research approach is thorough, involving detailed analysis of accounting practices and governance, alongside extensive channel checks.

Independent & Unbiased Research

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/pg-electroplast-ltd" target="_blank" data-smartkarma-citation="entities:17782:1" rel="noopener">PG Electroplast (PGEL IN)</a> is under limelight after the management cut its revenue guidance from 33% to 21-23%, within a single quarter.</li>
<li>The management has also flagged concerns regarding RAC demand which has affected performance.</li>
<li>Additionally, between Feb–Jun 2025, relatives of the CFO sold ~INR 376 mn worth of shares, mostly in June, shortly before the guidance cut, raising potential governance concerns.</li>
</ul>



PG Electroplast (PGEL IN) is under limelight after the management cut its revenue guidance from 33% to 21-23%, within a single quarter.
The management has also flagged concerns regarding RAC demand which has affected performance.
Additionally, between Feb–Jun 2025, relatives of the CFO sold ~INR 376 mn worth of shares, mostly in June, shortly before the guidance cut, raising potential governance concerns.


PG Electroplast: KMP Selling and Lowering Guidance